SOUTH SAN FRANCISCO, Calif.--()--Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2012 full year financial results on February 12, 2013, after close of market.
Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a conference call at 2:30 p.m. PST (5:30 p.m. EST) on February 12, 2013, to discuss fourth quarter and 2012 full year financial results and operating activities. A press release outlining the financial results will be publicly distributed prior to the call.
The Fluidigm conference call can be accessed by calling (877) 556-5248 (domestic toll-free) or (720) 545-0029 (international toll). There will be a Q&A period during the call.
Fluidigm will also provide a live stream of its Q4 and 2012 full year financial results conference call for investors at: http://investors.fluidigm.com/events.cfm. The link will not be active until 2:15 p.m. PST on February 12, 2013.
A telephone replay of the teleconference will be available 90 minutes after the end of the call at (855) 859-2056 (domestic toll-free), or (404) 537-3406 (international toll), access code 90773935. The conference call will also be archived on the Fluidigm investor’s page at: http://investors.fluidigm.com.
Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs), assays and other reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets four microfluidic systems, including thirteen different IFCs, to leading academic institutions, diagnostic laboratories, and pharmaceutical, biotechnology and Ag-Bio companies. Fluidigm products are marketed for research purposes only (not for diagnostic use).
For more information, please visit www.fluidigm.com.
Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.